Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS)

由 Trieste, L, Della Casa Alberighi, O, Turchetti, G, Pierotti, F, Accame, L, Lorenzoni, V, Frenkel, J, Gattorno, M, Quartier, P, Martini, A
發表在 Pediatr Rheumatol Online J (2015)

The RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS)

由 Della Casa Alberighi, O, Trieste, L, Accame, L, Lorenzoni, V, Pierotti, F, Federici, S, Gattorno, M, Quartier, P, Ngoc, P Duong, Rojas, N Cabrera, Martini, A, Turchetti, G
發表在 Pediatr Rheumatol Online J (2015)